EMN - Eastman Chemical Company
NYSE
->
Basic Materials
->
Chemicals
Kingsport,
United States
Type: Equity
EMN price evolution
EMN
| (in millions $) | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $499 | $548 | $439 | $410 |
| Short term investments | ||||
| Net receivables | $1274 | $1154 | $1149 | $1205 |
| Inventory | $1769 | $1683 | $1721 | $1960 |
| Total current assets | $3638 | $3481 | $3567 | $3671 |
| Long term investments | ||||
| Property, plant & equipment | $5535 | $5548 | $5426 | $5402 |
| Goodwill & intangible assets | $4754 | $4784 | $4791 | $4877 |
| Total noncurrent assets | $11110 | $11152 | $11027 | $11100 |
| Total investments | ||||
| Total assets | $14748 | $14633 | $14594 | $14771 |
| Current liabilities | ||||
| Accounts payable | $1878 | $2035 | $1940 | $1943 |
| Deferred revenue | ||||
| Short long term debt | $740 | $541 | $640 | $844 |
| Total current liabilities | $2618 | $2576 | $2615 | $2787 |
| Long term debt | $4340 | $4305 | $4580 | $4593 |
| Total noncurrent liabilities | $6522 | $6527 | $6555 | $6632 |
| Total debt | $5080 | $4846 | $5220 | $5437 |
| Total liabilities | $9140 | $9103 | $9170 | $9419 |
| Shareholders' equity | ||||
| Retained earnings | $9559 | $9490 | $9274 | $9190 |
| Other shareholder equity | -$328 | -$319 | -$294 | -$271 |
| Total shareholder equity | $5538 | $5458 | $5352 | $5281 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $548 | $493 | $459 | $564 |
| Short term investments | ||||
| Net receivables | $1154 | $1277 | $1580 | $1515 |
| Inventory | $1683 | $1894 | $1504 | $1379 |
| Total current assets | $3481 | $3778 | $4646 | $3541 |
| Long term investments | $156 | |||
| Property, plant & equipment | $5548 | $5371 | $4996 | $5549 |
| Goodwill & intangible assets | $4784 | $4874 | $5003 | $6257 |
| Total noncurrent assets | $11152 | $10889 | $10873 | $12542 |
| Total investments | ||||
| Total assets | $14633 | $14667 | $15519 | $16083 |
| Current liabilities | ||||
| Accounts payable | $2035 | $1319 | $2133 | $1689 |
| Deferred revenue | ||||
| Short long term debt | $541 | $1126 | $747 | $349 |
| Total current liabilities | $2576 | $3251 | $2971 | $2038 |
| Long term debt | $4305 | $4025 | $4412 | $5269 |
| Total noncurrent liabilities | $6527 | $6180 | $6760 | $7937 |
| Total debt | $4846 | $5151 | $5159 | $5618 |
| Total liabilities | $9103 | $9514 | $9731 | $9975 |
| Shareholders' equity | ||||
| Retained earnings | $9490 | $8973 | $8557 | $8080 |
| Other shareholder equity | -$319 | -$204 | -$182 | -$273 |
| Total shareholder equity | $5458 | $5153 | $5704 | $6023 |
| (in millions $) | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2310 | $2207 | $2267 | $2324 |
| Cost of revenue | $1778 | $1783 | $1740 | |
| Gross Profit | $532 | $464 | $484 | $584 |
| Operating activities | ||||
| Research & development | $59 | $60 | $60 | |
| Selling, general & administrative | $191 | $160 | $185 | |
| Total operating expenses | $256 | $295 | $218 | $242 |
| Operating income | $276 | $266 | $342 | |
| Income from continuing operations | ||||
| EBIT | $263 | $255 | $323 | |
| Income tax expense | $49 | $114 | $20 | -$3 |
| Interest expense | $49 | -$52 | $57 | $54 |
| Net income | ||||
| Net income | $165 | $310 | $178 | $272 |
| Income (for common shares) | $165 | $178 | $272 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9210 | $10580 | $8473 | |
| Cost of revenue | $8443 | $6498 | ||
| Gross Profit | $2061 | $2137 | $1975 | |
| Operating activities | ||||
| Research & development | $264 | $226 | ||
| Selling, general & administrative | $726 | $654 | ||
| Total operating expenses | $1045 | $941 | $1226 | |
| Operating income | $1196 | $749 | ||
| Income from continuing operations | ||||
| EBIT | $1156 | $729 | ||
| Income tax expense | $191 | $181 | $41 | |
| Interest expense | -$215 | $182 | $210 | |
| Net income | ||||
| Net income | $894 | $793 | $478 | |
| Income (for common shares) | $793 | $478 | ||
| (in millions $) | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $165 | $178 | $272 | |
| Operating activities | ||||
| Depreciation | $127 | $120 | $119 | |
| Business acquisitions & disposals | $24 | -$3 | ||
| Stock-based compensation | ||||
| Total cash flows from operations | -$16 | $514 | $410 | |
| Investing activities | ||||
| Capital expenditures | -$186 | -$236 | -$241 | |
| Investments | ||||
| Total cash flows from investing | -$179 | -$432 | -$182 | -$246 |
| Financing activities | ||||
| Dividends paid | -$95 | -$376 | -$94 | -$94 |
| Sale and purchase of stock | $23 | -$54 | ||
| Net borrowings | $244 | -$204 | -$205 | |
| Total cash flows from financing | $148 | -$888 | -$299 | -$353 |
| Effect of exchange rate | -$2 | $1 | -$4 | |
| Change in cash and equivalents | -$49 | $55 | $29 | -$189 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $793 | $857 | $478 | |
| Operating activities | ||||
| Depreciation | $477 | $538 | $574 | |
| Business acquisitions & disposals | $997 | $553 | -$1 | |
| Stock-based compensation | ||||
| Total cash flows from operations | $975 | $1619 | $1455 | |
| Investing activities | ||||
| Capital expenditures | -$624 | -$578 | -$383 | |
| Investments | ||||
| Total cash flows from investing | -$432 | $392 | -$29 | -$394 |
| Financing activities | ||||
| Dividends paid | -$376 | -$381 | -$375 | -$358 |
| Sale and purchase of stock | -$1002 | -$1000 | -$60 | |
| Net borrowings | $76 | -$350 | -$307 | |
| Total cash flows from financing | -$888 | -$1321 | -$1690 | -$704 |
| Effect of exchange rate | $1 | -$12 | -$5 | $3 |
| Change in cash and equivalents | $55 | $34 | -$105 | $360 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $9.11B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $925.00M |
| Revenue Q/Q | -4.23% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 6.30% |
| ROE | 17.11% |
| Debt/Equity | 1.67 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.39 |
| Quick ratio | 0.71 |